ArticleClinical nuclear medicine2014

A pilot study of the value of 18F-fluoro-deoxy-thymidine PET/CT in predicting viable lymphoma in residual 18F-FDG avid masses after completion of therapy.

Esther Mena et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.